# the Effect of HCG Treatment as a Cardiovascular Disease Morbidity Factor in Sjogren Syndrome Patients

> **NCT02381587** · — · UNKNOWN · sponsor: **Meir Medical Center** · enrollment: 500 (estimated)

## Conditions studied

- Primary Sjogren Syndrome With Multisystem Involvement

## Interventions

- **OTHER:** Retrospective study

## Key facts

- **NCT ID:** NCT02381587
- **Lead sponsor:** Meir Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-04
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2015-03-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02381587

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02381587, "the Effect of HCG Treatment as a Cardiovascular Disease Morbidity Factor in Sjogren Syndrome Patients". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT02381587. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*